Objective: To investigate the molecular mechanism underlying T-bet mediated anti-neoplastic effects of cytokine induced killer (CIK) cells.
Introduction
Cytokine-induced killer (CIK) cells consist of a peripheral blood mononuclear cell-derived heterogeneous cell population which has been treated with different cytokines (CD3McAb, IL-2, IFN-γ, IL-1α) for a period of time. These cells possess potent anti-neoplastic activity similar to T lymphocytes, and also exhibit non-MHC-restricted cytotoxicity similar to NK cells [1] [2] [3] . Co-culture of dendritic cells (DCs) and CIK cells has been shown to generate DC-CIK cells which are characterized by rapid proliferation, high cytotoxic activity and fewer side effects in clinical practice [4, 5] .
T-bet, a transcription factor that controls IFN-γ expression in Th1 cells [6] , plays a very important role in the development of Th1 cells through activation of IFN-γ gene. GATA-3, a transcription factor that controls IL-4 expression in Th2 cells [7] , also plays a positive role in the development of Th2 cells through activation of IL-4 gene. Foxp3, a transcription inhibitor [8] , plays a considerable role in the development of CD4+CD25+Treg cells through increasing IL-10, TGF-β and other immunosuppressive cytokines. The immune balance between Th1, Th2 and Treg cells along with an appropriate immune response from these three cell populations plays an important role during cancer therapy. The immune response of DC-CIK cells was previously reported to be mediated by Th1 cells [9] . The anti-neoplastic effects of DC-CIK cells are directly and indirectly regulated by a number of cytokines. In this study, we investigated the molecular mechanisms underlying the anti-neoplastic effects of DC-CIK cells.
Subjects and Methods
Tetrazolium bromide (MTT) was purchased from Sigma (USA). Fetal bovine serum (FBS) and RPMI-1640 medium was from Gibco, USA. Trizol and the RT-PCR kit were from Wuhan Feiling, China. Mouse anti-human T-bet monoclonal antibody was from Wuhan Boster. Rabbit anti-Foxp3 polyclonal antibody, rabbit anti-GATA3 polyclonal antibody, and rabbit anti-GAPDH polyclonal antibody were from Cell Signaling, USA. Appropriate secondary antibody and the ECL kit were from Pierce, USA. Protein molecular weight markers were purchased from Fermentas, USA. Mouse anti-human CD3 and CD25 conjugated to FITC, mouse anti-human CD8, CD56, CD19 and CD4 conjugated to PE and appropriate isotype control antibodies were purchased from Becton, Dickinson and Company Biosciences, USA.
Acute B-lymphoblastic leukemia cell line (B95), acute T-lymphoblastic leukemia cell line (Jhhan) and megakaryocytic leukemia cell line (M07e) were kindly provided by Professor Mo Yang, Hong Kong University. The B95, Jhhan and M07e cells were cultured in RPMI 1640 medium supplemented with 10% FBS. Cells were maintained at 37 0 C in a humidified atmosphere of 5% CO2. Cells in the logarithmic growth phase were harvested and cell viability was greater than 95%.
Generation of DC-CIK cells:
Bone marrow mononuclear cells obtained from leukemic children were grown in DC base media supplemented with 1000 U/ml GM-CSF, 1000 U/ml IL-4 and 10 μg/L TNF-α. Cells were maintained at 37 0 C in a humidified atmosphere of 5% CO2 for 10 days, resulting in the induction of DCs in this cell population. Peripheral blood mononuclear cells (PBMCs) were obtained from leukemic children by Ficoll gradient centrifugation as previously described [1] and cell density was adjusted to 1×10 9 cells/L. Co-culture of DCs and PBMCs was performed in RPMI 1640 medium supplemented with 10% FBS. On the first day of culture, 1×10 6 U/L IFN-γ was added. Cells were then incubated for 24 h before the addition of, 3×10 5 U/L rIL-2 and 50 μg/ml CD3McAb. Medium was replenished every 4 days with fresh medium containing rhIL-2, and CD3McAb. Cells were harvested after 10 days of culture and cell density was adjusted to 2×10 8 
Detection of mRNA expression of Foxp3 and GATA3 by reverse transcription-polymerase chain reaction (RT-PCR):
1) RNA extraction: Total RNA was extracted from cells in the different groups using TRIZOL according to the manufacturer's recommendations. Integrity of the RNA samples was determined by agarose gel electrophoresis.
2) Reverse transcription-polymerase chain reaction (RT-PCR): Two-step RT-PCR was performed using a PCR kit from Takara (USA) according to the manufacturer's recommenddations. The target genes were Foxp3 and GATA-3, and the internal reference was β-actin. Primers were designed using the Primer 5.0 software and synthesized by Sangon Biotech Co. Primer sequences are displayed in Table 1 . The amplified products were separated on 1.5% agarose gels and analyzed using a gel imaging analysis system. The density of each band was normalized to that of β-actin.
Detection of protein expression of Foxp3 and GATA3
by Western blot: 1) Preparation of total protein: Cells in the different treatment groups were washed thrice with ice cold PBS and harvested in lysis buffer (5×10 6 cells/50 μL of lysis buffer) containing 0.5 mol/L Tris-HCL (pH 8.0), 0.15 mol/L NaCl, 0.02% sodium azide, 0.1% SDS, 100 mg/L phenylmethylsulphonyl fluoride (PMSF), 1 mg/L aprotinin, 1% Nonidet P-40 (NP-40) and 0.5% sodium deoxycholate. The lysates were centrifuged at 12,000 rpm/s for 20 min at 4 0 C and protein concentration in the supernatant was determined by the Bradford method. The lysates were aliquoted and stored at -80°C. 2) Western Blotting: Protein lysates were separated on SDS-PAGE and transferred onto PVDF membranes. The membranes were blocked with 5% non-fat milk in TBST for 3 h and then incubated overnight with rabbit anti-Foxp3 (1:2000 dilution) or GATA3 (1:2000 dilution) at 4°C. The membranes were washed and incubated with horseradish peroxidase conjugated IgG for 2 h at room temperature. Rabbit anti-GAPDH primary antibody (1:1000 dilution) was used as an internal reference. Membranes were washed and color was developed using the ECL kit according to the manufacturer's instructions. The integral (Fig. 2) .
Levels of IL-2 and IFN-γ in DC-CIK cells:
We used ELISA to show that the levels of IL-2 and IFN-γ in the supernatant of DC-CIK cells exhibited a significant increase in a time dependent manner. The levels of IFN-γ in the supernatant of DC-CIK cells (1×10 6 ) increased gradually from 325 pg/ml at 2 hours after induction to a maximal level of 1058 pg/ml at 24 h after induction. There was also a gradual increase in IL-2 levels from 245 pg/ml at 2 h of induction to a maximal level of 970 pg/ml after 24 h of induction ( Fig. 3 and 4) . (Fig 6) .
Protein expressions of Foxp3 and GATA3:
We demonstrated a baseline expression of Foxp3 (26 kDa) and GATA3 (45kDa) in the negative control (Fig. 7) .
Discussion
Adoptive immunotherapy is a useful strategy used in the treatment of various tumors. It is performed by isolation of potential immune cells from cancer patients and treating them with a number of immunocytokines, resulting in increased numbers as well as enhanced activation and improved T-bet(5μ g/ml)
T-bet(10μ g/ml) heterogenous cell population, with anti-neoplastic properties similar to T lymphocytes and have been used in adoptive immunotherapy for cancers. The classical induction of DC-CIK cells was first described in 1991 [1] and they have been shown to exert non-MHC-restricted cytotoxicity similar to NK cells [10, 11] . DC-CIK cells are less dependent on IL-2 and have a higher proliferative activity and more potent cytotoxic activity when compared with LAK cells, making it possible to avoid the severe side effects caused by IL-2 [1] . While a majority of DC-CIK cells express T lymphocyte markers such as TCRα/β, TCRγ/δ, CD3, CD4 and CD8, a fraction of these cells express the marker for NK cells [12, 13] .
In the present study, we demonstrated that the main effector cells in the DC-CIK cell population GAPDH 35KD
Foxp3 26KD
GATA3 45KD Our data demonstrated that DC-CIK cells exerted cytotoxic effects on different cancer cells, with the highest cytotoxic activity against B95 cells. The cytotoxic activity against B95 cells was greater than 60% when the ratios of effector cells to target cells were 10:1 and 20:1. However, increasing the ratio of effector cells to target cells had no effect on the cytotoxic activity of DC-CIK cells against Jhhan cells and M07e cells, suggesting differences in the anti-neoplastic activity of DC-CIK against different types of cancer cells. It will be interesting to investigate the mechanism underlying such differences.
Our data confirmed these studies and demonstrated the T-bet-mediated in vitro antineoplastic effects of DC-CIK. We also used flow cytometry to show that blocking the pathway with T-bet monoclonal antibody resulted in a higher proportion of CD4 + CD25 + Treg cells when compared with the negative control group. These data suggested that CD4 + CD25 + Treg cells were involved in the T-bet mediated down-stream pathway. In addition, we demonstrated that T-bet monoclonal antibody treatment resulted in higher levels of Foxp3 and GATA3 when compared with the negative control group, suggesting that Foxp3 and GATA3 were involved in the T-bet mediated down-stream mechanism.
The immune balance between Th1 and Th2 cells along with an appropriate immune response from these two cell populations play an important role during cancer therapy. The immune response of DC-CIK cells was previously reported to be mediated by Th1 cells. While T-bet is the major regulator promoting Th1 cell differentiation, GATA3 is the critical regulator facilitating Th2 cell differentiation.
The CD4 + CD25 + Treg cell population consists of a group of novel regulatory cells which exert a negative regulatory effect on the immune response and play a role in immune regulation by Th1 cells and Th2 cells [6, 8] . Foxp3 plays a key role in regulating the differentiation of CD4 + CD25 + Treg cells [7, 14] .
We showed that T-bet treatment resulted in an increased expression of Foxp3, GATA3 and CD4 + CD25 + Treg. These findings suggested that blocking the Th1 pathway could result in an increase in the number of Treg cells and Th2 cells and implied that the anti-neoplastic effects of DC-CIK cells were mediated through activation of the Th1 pathway and suppression of Treg and the Th2 pathway. We propose the following pathway to explain the mechanism underlying the antineoplastic effects of DC-CIK cells: (1) The T-bet pathway, together with the first signal, promotes the proliferation and activation of lymphocytes, leading to a shift from a Th0 response to a Th1 response along with an inhibition of the shift from Th0 response to Treg and Th2 response. These effects are accompanied by increased production of IL-2 and IFN-γ (Th1 cytokines), which promotes the secretion of cytoplasmic granules containing BLT esterase. Cytoplasmic granules penetrate the target cells, resulting in exocytosis and cell lysis. [15] . Limitations and Applications: Further research in vivo would provide additional evidence to support our conclusion. The study should discuss other killing-tumor methods of cytokine-induced killer cell, such as Fas-FasL method.
Conclusion
In summary, our results demonstrated the cytotoxic effects of cytokine induced killer cells.
Foxp3 and GATA3 played a role in the T-bet mediated anti-neoplastic effects of DC-CIK cells, characterized by activation of the Th1 pathway and suppression of the Th2 and Treg pathways. Our results provide a theoretical basis for adoptive immunotherapy for leukemia and can help elucidate potential new molecular mechanisms underlying cancer immunotherapy.
